PO007LBA/#1550 Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study

التفاصيل البيبلوغرافية
العنوان: PO007LBA/#1550 Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
المؤلفون: Lee, Jung-Yun, Makker, Vicky, Manso, Luis, González-Martín, Antonio, Ługowska, Iwona, Lorusso, Domenica, Banerjee, Susana, Liao, John, Lu, Chien-Hsing, Prasongsook, Naiyarat, Melichar, Bohuslav, Chen, Kai, Mcewen, Robert, Michelini, Flavia, Puvvada, Soham, Meric-Bernstam, Funda, Oaknin, Ana
المصدر: Plenary 02: Changing the Landscape of Endometrial Cancer
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/ijgc-2023-igcs.7
DOI: 10.1136/ijgc-2023-IGCS.7
الإتاحة: https://doi.org/10.1136/ijgc-2023-igcs.7Test
رقم الانضمام: edsbas.EEA5773A
قاعدة البيانات: BASE